US9553061055
US9553061055
West Pharmaceutical Services, I
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 90/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±40.7% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.
Beta (Market Relation)
1.13x
Above averageVolatility (5Y p.a.)
40.7% p.a.
5-Year HorizonMax Drawdown (5Y)
-59.6%
5-Year HorizonSharpe Ratio
-0.12
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +35.6% |
| 3 Years | 43.4% | -53.9% | -0.1 | -1.7% |
| 5 Years | 40.7% | -59.6% | -0.12 | -2.3% |
| 10 Years | 34.6% | -59.6% | 0.42 | +17% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 46.9 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -59.6% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
10 ISS Score: 10 / 10
Board Risk
4 ISS Score: 4 / 10
Short Ratio
4.89